These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20863399)

  • 41. Evaluating the effectiveness of selected community-level interventions on key maternal, child health, and prevention of mother-to-child transmission of HIV outcomes in three countries (the ACCLAIM Project): a study protocol for a randomized controlled trial.
    Woelk GB; Kieffer MP; Walker D; Mpofu D; Machekano R;
    Trials; 2016 Feb; 17():88. PubMed ID: 26883307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementation and Operational Research: Effects of Antenatal Care and HIV Treatment Integration on Elements of the PMTCT Cascade: Results From the SHAIP Cluster-Randomized Controlled Trial in Kenya.
    Turan JM; Onono M; Steinfeld RL; Shade SB; Owuor K; Washington S; Bukusi EA; Ackers ML; Kioko J; Interis EC; Cohen CR
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):e172-81. PubMed ID: 25967269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mothers' attitudes towards using services preventing mother-to-child HIV/AIDS transmission in Zimbabwe: an interview survey.
    Chivonivoni C; Ehlers VJ; Roos JH
    Int J Nurs Stud; 2008 Nov; 45(11):1618-24. PubMed ID: 18502426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare workers' perspectives on availability and accessibility of the prevention of mother-to-child-transmission programme in North West province, South Africa.
    Habedi D
    Afr J AIDS Res; 2020 Mar; 19(1):24-33. PubMed ID: 32200723
    [No Abstract]   [Full Text] [Related]  

  • 46. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
    Tesfaye DJ; Hibistu DT; Abebo TA; Asfaw FT; Lukas K; Laelago T; Turuse EA; Kebede HG; Altaye AA; Bekele FB
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):82. PubMed ID: 30819147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study.
    Tuller DM; Bangsberg DR; Senkungu J; Ware NC; Emenyonu N; Weiser SD
    AIDS Behav; 2010 Aug; 14(4):778-84. PubMed ID: 19283464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic and social factors are some of the most common barriers preventing women from accessing maternal and newborn child health (MNCH) and prevention of mother-to-child transmission (PMTCT) services: a literature review.
    hIarlaithe MO; Grede N; de Pee S; Bloem M
    AIDS Behav; 2014 Oct; 18 Suppl 5():S516-30. PubMed ID: 24691921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dramatic and sustained increase in HIV-testing rates among antenatal attendees in Eastern Uganda after a policy change from voluntary counselling and testing to routine counselling and testing for HIV: a retrospective analysis of hospital records, 2002-2009.
    Byamugisha R; Tylleskär T; Kagawa MN; Onyango S; Karamagi CA; Tumwine JK
    BMC Health Serv Res; 2010 Oct; 10():290. PubMed ID: 20946632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active pediatric HIV case finding in Kenya and Uganda: A look at missed opportunities along the prevention of mother-to-child transmission of HIV (PMTCT) cascade.
    Gill MM; Natumanya EK; Hoffman HJ; Okomo G; Taasi G; Guay L; Masaba R
    PLoS One; 2020; 15(6):e0233590. PubMed ID: 32484815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of mother-to-child transmission of HIV infection: views and perceptions about swallowing nevirapine in rural Lilongwe, Malawi.
    O'Gorman DA; Nyirenda LJ; Theobald SJ
    BMC Public Health; 2010 Jun; 10():354. PubMed ID: 20565930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Costs and benefits of multidrug, multidose antiretroviral therapy for prevention of mother-to-child transmission of HIV in the Dominican Republic.
    Schmidt NC; Roman-Pouriet J; Fernandez AD; Beck-Sagué CM; Leonardo-Guerrero J; Nicholas SW
    Int J Gynaecol Obstet; 2012 Mar; 116(3):219-22. PubMed ID: 22196992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exclusive breastfeeding among women taking HAART for PMTCT of HIV-1 in the Kisumu Breastfeeding Study.
    Okanda JO; Borkowf CB; Girde S; Thomas TK; Lecher SL
    BMC Pediatr; 2014 Nov; 14():280. PubMed ID: 25380718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women.
    McCabe CJ; Goldie SJ; Fisman DN
    PLoS One; 2010 Apr; 5(4):e10154. PubMed ID: 20405011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnant women's retention and associated health facility characteristics in the prevention of mother-to-child HIV transmission in Indonesia: cross-sectional study.
    Lumbantoruan C; Kelaher M; Kermode M; Budihastuti E
    BMJ Open; 2020 Sep; 10(9):e034418. PubMed ID: 32973049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lay health worker experiences administering a multi-level combination intervention to improve PMTCT retention.
    DiCarlo A; Fayorsey R; Syengo M; Chege D; Sirengo M; Reidy W; Otieno J; Omoto J; Hawken MP; Abrams EJ
    BMC Health Serv Res; 2018 Jan; 18(1):17. PubMed ID: 29321026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.